Abbott Laboratories (ABT)vsInteger Holdings Corp (ITGR)
ABT
Abbott Laboratories
$107.28
-1.87%
HEALTHCARE · Cap: $184.98B
ITGR
Integer Holdings Corp
$126.42
-0.21%
HEALTHCARE · Cap: $4.31B
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 2542% more annual revenue ($48.23B vs $1.83B). ABT leads profitability with a 9.8% profit margin vs 5.7%. ABT appears more attractively valued with a PEG of 1.52. ABT earns a higher WallStSmart Score of 52/100 (C-).
ABT
Buy52
out of 100
Grade: C-
ITGR
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-43.6%
Fair Value
$76.57
Current Price
$107.28
$30.71 premium
Margin of Safety
+6.6%
Fair Value
$93.36
Current Price
$126.42
$33.06 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Generating 1.2B in free cash flow
Reasonable price relative to book value
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
Earnings declined 43.7%
Grey zone — moderate risk
5.7% margin — thin
Weak financial health signals
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap, Free Cash Flow. Revenue growth of 14.5% demonstrates continued momentum.
Bull Case : ITGR
The strongest argument for ITGR centers on Price/Book.
Bear Case : ABT
The primary concerns for ABT are PEG Ratio, P/E Ratio, EPS Growth.
Bear Case : ITGR
The primary concerns for ITGR are Altman Z-Score, Profit Margin, Piotroski F-Score. A P/E of 42.5x leaves little room for execution misses.
Key Dynamics to Monitor
ABT carries more volatility with a beta of 0.58 — expect wider price swings.
ABT is growing revenue faster at 14.5% — sustainability is the question.
ABT generates stronger free cash flow (1.2B), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ABT scores higher overall (52/100 vs 41/100) and 14.5% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Integer Holdings Corp
HEALTHCARE · MEDICAL DEVICES · USA
Integer Holdings Corporation is an outsourced manufacturer of medical devices in the United States, Puerto Rico, Costa Rica, and internationally. The company is headquartered in Plano, Texas.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?